V022-7430 Screening compound: 2-[(4-ethoxyphenyl)methyl]-1-(2,4,5-trimethoxyphenyl)-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine

V022-7430 Screening compound: 2-[(4-ethoxyphenyl)methyl]-1-(2,4,5-trimethoxyphenyl)-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine
V022-7430 Screening compound: 2-[(4-ethoxyphenyl)methyl]-1-(2,4,5-trimethoxyphenyl)-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-7430
2-[(4-ethoxyphenyl)methyl]-1-(2,4,5-trimethoxyphenyl)-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-7430

Molecular Formula

C26H32N2O4 (C26 H32 N2 O4)

Compound Name

2-[(4-ethoxyphenyl)methyl]-1-(2,4,5-trimethoxyphenyl)-1H,2H,3H,4H,5H-pyrrolo[1,2-a][1,4]diazepine

IUPAC name

2-[(4-ethoxyphenyl)methyl]-1-(245-trimethoxyphenyl)-1H2H3H4H5H-pyrrolo[12-a][14]diazepine

SMILES

CCOc1ccc(CN(CCCn2c3ccc2)C3c(cc(c(OC)c2)OC)c2OC)cc1

InChI

InChI=1S/C26H32N2O4/c1-5-32-20-11-9-19(10-12-20)18-28-15-7-14-27-13-6-8-22(27)26(28)21-16-24(30-3)25(31-4)17-23(21)29-2/h6,8-13,16-17,26H,5,7,14-15,18H2,1-4H3/t26-/m1/s1

InChI Key

UQABIWPPEMKKAQ-AREMUKBSSA-N

MDL Number (MFCD)

MFCD19893165

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

436.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.333

Distribution Coefficient, logD

4.138

Water Solubility, LogSw

-4.14

Polar Surface Area

35.957

Acid Dissociation Constant (pKa)

25.05

Base Dissociation Constant (pKb)

7.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.46

V022-7430 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V022-7430 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-7430?
Check Price and Availability of V022-7430, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-7430 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-7430
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-7430
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-7430 available by request